Literature DB >> 222725

Effects of 8-substituted analogs of cyclic adenosine 3',5'-monophosphate on in vivo and in vitro syntheses of beta-galactosidase in Escherichia coli.

T Ito, T Yokota, Y Sasaki, N Suzuki, T Sowa.   

Abstract

Several 8-substituted alkylthio and alkylamino cyclic adenosine 3',5'-monophosphate (cAMP) derivatives were tested for their ability to stimulate beta-galactosidase synthesis in Estherichia coli in vivo and in vitro and to inhibit the cAMP phosphodiesterase activity of E. coli. Stimulation of beta-galactosidease synthesis in vivo by cAMP derivatives decreased with increasing length of the unbranched carbon chain of the substituent. On the other hand, the stimulation in vitro was increased as the carbon chain elongated. The 8-decylthio- and 8-dodecylthio-cAMP compounds stimulated beta-galactosidase synthesis almost eight-fold compared with cAMP, whereas 8-undecyl-, 8-dodectyl-, and 8-tridecylamino-cAMP stimulated beta-galactosidase synthesis about threefold. However, in in vitro experiments with a phosphodiesterase-deficient strain of E. coli, the Crooks strain, the stimulatory effects of the derivatives disappeared, except for 8-dodecylthio cAMP which stimulated beta-galactosidase about 1.4- to 1.6-fold. All derivatives were quite resistant to hydrolysis by phosphodiesterase. Most derivatives competitively inhibited the hydrolysis of cAMP by phosphodiesterase.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222725      PMCID: PMC218089          DOI: 10.1128/jb.138.3.671-677.1979

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  18 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Effect of adenosine 3',5'-monophosphate analogues on the activity of the cyclic adenosine 3',5'-monophosphate receptor in Escherichia coli.

Authors:  W B Anderson; R L Perlman; I Pastan
Journal:  J Biol Chem       Date:  1972-05-10       Impact factor: 5.157

3.  Purification and DNA-binding properties of the catabolite gene activator protein.

Authors:  A D Riggs; G Reiness; G Zubay
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

4.  Establishment of repression by lambdoid phage in catabolite activator protein and adenylate cyclase mutants of Escherichia coli.

Authors:  T Grodzicker; R R Arditti; H Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

5.  In vitro transcription of the gal operon requires cyclic adenosine monophosphate and cyclic adenosine monophosphate receptor protein.

Authors:  S P Nisseley; W B Anderson; M E Gottesman; R L Perlman; I Pastan
Journal:  J Biol Chem       Date:  1971-08-10       Impact factor: 5.157

6.  Lac DNA, RNA polymerase and cyclic AMP receptor protein, cyclic AMP, lac repressor and inducer are the essential elements for controlled lac transcription.

Authors:  B De Crombrugghe; B Chen; W Anderson; P Nissley; M Gottesman; I Pastan; R Perlman
Journal:  Nat New Biol       Date:  1971-06-02

7.  Requirement of adenosine-3',5'-cyclic monophosphate for L-arabinose isomerase synthesis in Escherichia coli.

Authors:  T Nakazawa; T Yokota
Journal:  J Bacteriol       Date:  1973-03       Impact factor: 3.490

8.  Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine.

Authors:  R W BUTCHER; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

9.  Cyclic adenosine monophosphate in bacteria.

Authors:  I Pastan; R Perlman
Journal:  Science       Date:  1970-07-24       Impact factor: 47.728

10.  Adenosine 3':5'-cyclic monophosphate concentration in the bacterial host regulates the viral decision between lysogeny and lysis.

Authors:  J S Hong; G R Smith; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.